Prenatal screening in the first trimester of pregnancy

Prenatal Diagnosis

Volumn 18, Issue 6, 1998, Pages 537-543

  Wheeler, D M ^a   Sinosich, M J ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ALGORITHM; ANEUPLOIDY; ARTICLE; AUSTRALIA; CHORION VILLUS SAMPLING; DIAGNOSTIC ACCURACY; DOWN SYNDROME; EARLY DIAGNOSIS; FEMALE; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN EXPERIMENT; MATERNAL AGE; NORMAL HUMAN; PRENATAL SCREENING; PRIORITY JOURNAL;

ABNORMALITIES; ADULT; ANEUPLOIDY; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHORIONIC VILLI SAMPLING; CHROMOSOME ABERRATIONS; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; MATERNAL AGE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS;

EID: 0031781815     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199806)18:6<537::AID-PD288>3.0.CO;2-Q     Document Type: Article

References (22)

1. Australian Institute of Health and Welfare (AIHW) National Perinatal Statistics Unit (1994). Australia's Mothers and Babies 1991, Sydney, Australia.
2. Bersinger, N., Brizot, M.L., Johnson, A., Snijders, R.J.M., Abbott, J., Schneider, H., Nicolaides, K.H. (1994). First trimester maternal serum pregnancy-associated plasma protein-A and pregnancy-specific β1-glycoprotein in fetal trisomies, Br. J. Obstet. Gynaecol., 101, 970-974.
3. Brambati, B., Lanzani, A., Tului, L. (1991). Ultrasound and biochemical assessment of first trimester pregnancy. In: Chapman, M., Grudzinskas, J. G., Chard, T. (Eds). The Embryo: Normal and Abnormal Development and Growth, London: Springer-Verlag, 181-194.
4. Brambati, B., Tului, L., Bonacchi, I., Shrimanker, K., Suzuki, Y., Grudzinskas, J.G. (1994). Serum PAPP-A and free β-hCG are first trimester screening markers for Down syndrome, Prenat. Diagn., 14, 1043-1047.
5. Brizot, M.L., Snijders, R.J.M., Bersinger, N.A., Kuhn, P., Nicolaides, K.H. (1994). Maternal serum pregnancy-associated plasma protein-A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy, Obstet. Gynaecol., 84, 918-922.
6. Cuckle, H.S., Wald, N.J., Thompson, S.G. (1987). Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alphafetoprotein, Br. J. Obstet. Gynaecol., 94, 387-402.
7. Cuckle, H.S., Wald, N.J. (1990). Screening for Down's Syndrome. In: Lilford, R. J. (Ed.). Prenatal Diagnosis and Prognosis, UK: Butterworth and Co.
8. El Farra, K., Grudzinskas, J.G. (1995). Will PAPP-A be a biochemical marker for screening of Down's syndrome in the first trimester?, Early Pregnancy: Biology and Medicine, 1, 4-12.
9. Hurley, P.A., Ward, R.H.T., Teisner, B., Iles, R.K., Lucas, M., Grudzinskas, J.G. (1993). Serum PAPP-A measurements in first-trimester screening for Down syndrome, Prenat. Diagn., 13, 903-908.
10. Macintosh, M.C.M., Brambati, B., Chard, T., Grudzinskas, J.G. (1993). Predicting fetal chromosome anomalies in the first trimester using pregnancy-associated plasma protein-A: a comparison of statistical methods, Meth. Inform. Med., 32, 175-179.
11. Reynolds, T.M., Penney, M.D. (1989). The mathematical basis of multivariate risk screening with special reference to screening for Down's syndrome associated pregnancy, Ann. Clin. Biochem., 27, 452-458.
12. Ryall, R.G., Staples, A.J., Robertson, E.F., Pollard, A.C. (1992). Improved performance in a prenatal screening programme for Down's syndrome incorporating serum-free hCG subunit analysis, Prenat. Diagn., 12, 251-261.
13. Ryall, R.G., Ranieri, E., Gjerde, E.M., Cocciolone, R., Thomas, D.W. (1996). Five year audit of the South Australian Maternal Serum Screening Programme (SAMSAS). Proceedings of the 20th Annual Meeting of the Human Genetics Society of Australasia, 46.
14. Scott, F., Wheeler, D., Sinosich, M.J., Boogert, A., Anderson, J., Edelman, D. (1996). First trimester aneuploidy screening using nuchal translucency, free beta-human chorionic gonadotrophin and maternal age, Aust. NZ J. Obstet. Gynaecol., 36, 381-384.
15. Sinosich, M.J., Teisner, B., Folkerson, J., Saunders, D.M., Grudzinskas, J.G. (1982). Radioimmunoassay for pregnancy-associated plasma protein-A, Clin. Chem., 5, 777-786.
16. Sinosich, M.J., Smith, D.H., Grudzinskas, J.G., Saunders, D.M., Westergaard, J.G., Teisner, B. (1983). The prediction of pregnancy failure by measurement of pregnancy-associated plasma protein-A (PAPP-A) following in vitro fertilisation and embryo transfer, Fertil. Steril., 40, 536-541.
17. Sinosich, M.J., Ferrier, A., Saunders, D.M. (1985). Monitoring of postimplantation embryo viability following successful in vitro fertilisation and embryo transfer by measurement of placental proteins, Fertil. Steril., 44, 70-74.
18. Sinosich, M.J. (1994a). Maternal serum screening in first and second trimester. Presented at Second Annual Meeting on Antenatal Screening for Down Syndrome - Limits and Achievements. Auckland, New Zealand (unpublished).
19. Sinosich, M.J. (1994b). Antenatal testing with pregnancy-associated markers, Clin. Biochem. Revs., 15, 3-7.
20. Snijders, R.J.M., Holzgreve, W., Cuckle, H., Nicholaides, K.H. (1994). Maternal age-specific risk for trisomies at 9-14 weeks' gestation, Prenat. Diagn., 14, 543-552.
21. Wald, N., Stone, R., Cuckle, H.S., Grudzinskas, J.G., Barkai, G., Brambati, B., Fuhrmann, W. (1992). First trimester concentrations of pregnancy-associated plasma protein-A and placental protein 14 in Down syndrome, BMJ, 305, 28.
22. Westergaard, J.G., Sinosich, M.J., Bugge, M., Madsen, L.T., Teisner, B., Grudzinskas, J.G. (1983). Pregnancy-associated plasma protein-A in the prediction of early pregnancy failure, Am. J. Obstet. Gynaecol., 145, 67-69.